Shao Kun Chuai

Guangzhou Burning Rock Medical Examination Institute Co., Ltd. is a holding company, which engages in Next-Generation Sequencing (NGS) diagnostics solutions for precision medicine in oncology. Its products are for different cancer types and clinical applications, ranging from companion diagnostics for targeted therapy and immunotherapy, benign or malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction, and tumor susceptibility tests. The company was founded by Han Yu Sheng, Wu Zhi Gang and Chuai Shao Kun on March 18, 2014 and is headquartered in Guangzhou, China.